Search results

• Finished

  Prism 302-A Three-Part, Phase 3, Randomized, Double-Blind, Placebo-Controlled, Four-Arm, Discontinuation Study to Evaluate the Efficacy and Safety of Subcutaneous Injections of BMN 165 Self Administered by Adults with Phenylketonuria

  Fuchs, G., Briggs, A., Crutcher, A., Yozwiak, J. & Amato, R.

  BioMarin Pharma Inc

  6/19/14 → 2/12/20

  Project: Research project